150 related articles for article (PubMed ID: 28420069)
1. Cathelicidin (LL-37) and its correlation with pro-oxidant, antioxidant balance and disease activity in systemic lupus erythematosus: a cross-sectional human study.
Sahebari M; Roshandel G; Saadati N; Saghafi M; Abdolahi N; Rezaieyazdi Z
Lupus; 2017 Aug; 26(9):975-982. PubMed ID: 28420069
[TBL] [Abstract][Full Text] [Related]
2. No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis.
Kienhöfer D; Hahn J; Schubert I; Reinwald C; Ipseiz N; Lang SC; Borràs ÈB; Amann K; Sjöwall C; Barron AE; Hueber AJ; Agerberth B; Schett G; Hoffmann MH
PLoS One; 2014; 9(12):e115474. PubMed ID: 25535966
[TBL] [Abstract][Full Text] [Related]
3. The behavior of neutrophil extracellular traps and NADPH oxidative activity in pediatric systemic lupus erythematosus: relation to disease activity and lupus nephritis.
El-Ghoneimy DH; Hesham M; Hasan R; Tarif M; Gouda S
Clin Rheumatol; 2019 Sep; 38(9):2585-2593. PubMed ID: 31030361
[TBL] [Abstract][Full Text] [Related]
4. Reduction of nitric oxide and DNA/RNA oxidation products are associated with active disease in systemic lupus erythematosus patients.
Iriyoda TMV; Stadtlober N; Lozovoy MAB; Delongui F; Costa NT; Reiche EMV; Dichi I; Simão ANC
Lupus; 2017 Sep; 26(10):1106-1111. PubMed ID: 28420072
[TBL] [Abstract][Full Text] [Related]
5. Association between serum total antioxidant status and flow-mediated dilation in patients with systemic lupus erythematosus: an observational study.
Sincer İ; Kurtoğlu E; Yılmaz Çoşkun F; Aktürk S; Vuruşkan E; Düzen İV; Saraçoğlu E; Aktürk E; Hidayet Ş
Anatol J Cardiol; 2015 Nov; 15(11):913-8. PubMed ID: 25868041
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
El-Banna HS; El Khouly RM; Gado SE
Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
[TBL] [Abstract][Full Text] [Related]
7. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity.
Wang G; Pierangeli SS; Papalardo E; Ansari GA; Khan MF
Arthritis Rheum; 2010 Jul; 62(7):2064-72. PubMed ID: 20201076
[TBL] [Abstract][Full Text] [Related]
8. LL-37 expression in the skin in systemic lupus erythematosus.
Sun CL; Zhang FZ; Li P; Bi LQ
Lupus; 2011 Aug; 20(9):904-11. PubMed ID: 21562016
[TBL] [Abstract][Full Text] [Related]
9. [The Correlation Between Serum Hcy Level and Clinical Indicators in Systemic Lupus Erythematosus Patients].
Ding XJ; Chen Y; Duan X; Wang L; Liu Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 50(4):619-621. PubMed ID: 31642246
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of P-glycoprotein and persistence of disease activity despite treatment in patients with systemic lupus erythematosus.
Perez-Guerrero EE; Gamez-Nava JI; Muñoz-Valle JF; Cardona-Muñoz EG; Bonilla-Lara D; Fajardo-Robledo NS; Nava-Zavala AH; Garcia-Cobian TA; Rincón-Sánchez AR; Murillo-Vazquez JD; Cardona-Müller D; Vazquez-Villegas ML; Totsuka-Sutto SE; Gonzalez-Lopez L
Clin Exp Med; 2018 Feb; 18(1):109-117. PubMed ID: 28243944
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors Associating with Pro-oxidant-antioxidant Balance; Neutrophils to Lymphocytes Ratio, Vitamin D, Heat Shock Protein 27, and Red Cell Distribution Width.
Ghazizadeh H; Mirinezhad MR; Seyedi SMR; Sadabadi F; Ahmadnezhad M; Jaberi N; Pasdar A; Ferns GA; Esmaily H; Ghayour-Mobarhan M
Arch Med Res; 2020 Apr; 51(3):261-267. PubMed ID: 32111498
[TBL] [Abstract][Full Text] [Related]
12. Significance of Lipid-Derived Reactive Aldehyde-Specific Immune Complexes in Systemic Lupus Erythematosus.
Wang G; Pierangeli SS; Willis R; Gonzalez EB; Petri M; Khan MF
PLoS One; 2016; 11(10):e0164739. PubMed ID: 27749917
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
14. Immunological studies of reactive oxygen species damaged catalase in patients with systemic lupus erythematosus: correlation with disease activity index.
Al-Shobaili HA; Al Robaee AA; Alzolibani AA; Rasheed Z
Immunol Invest; 2013; 42(3):191-203. PubMed ID: 23461612
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus.
Vordenbäumen S; Fischer-Betz R; Timm D; Sander O; Chehab G; Richter J; Bleck E; Schneider M
Lupus; 2010 Dec; 19(14):1648-53. PubMed ID: 20724351
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features.
Whittall-García LP; Torres-Ruiz J; Zentella-Dehesa A; Tapia-Rodríguez M; Alcocer-Varela J; Mendez-Huerta N; Gómez-Martín D
Lupus; 2019 Nov; 28(13):1549-1557. PubMed ID: 31619143
[TBL] [Abstract][Full Text] [Related]
17. Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus.
Wu Q; Yang Q; Sun H
Lupus; 2018 Nov; 27(13):2076-2085. PubMed ID: 30336754
[TBL] [Abstract][Full Text] [Related]
18. Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-α.
Mathian A; Mouries-Martin S; Dorgham K; Devilliers H; Barnabei L; Ben Salah E; Cohen-Aubart F; Garrido Castillo L; Haroche J; Hie M; Pineton de Chambrun M; Miyara M; Sterlin D; Pha M; Lê Thi Huong D; Rieux-Laucat F; Rozenberg F; Gorochov G; Amoura Z
Arthritis Rheumatol; 2019 May; 71(5):756-765. PubMed ID: 30507062
[TBL] [Abstract][Full Text] [Related]
19. Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?
Umare V; Nadkarni A; Nadkar M; Rajadhyksha A; Khadilkar P; Ghosh K; Pradhan VD
J Postgrad Med; 2017; 63(2):92-95. PubMed ID: 27531690
[TBL] [Abstract][Full Text] [Related]
20. Prooxidant-Antioxidant Balance in Patients with Systemic Lupus Erythematosus and Its Relationship with Clinical and Laboratory Findings.
Jafari SM; Salimi S; Nakhaee A; Kalani H; Tavallaie S; Farajian-Mashhadi F; Zakeri Z; Sandoughi M
Autoimmune Dis; 2016; 2016():4343514. PubMed ID: 26925260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
